Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis

European Neuropsychopharmacology

Volumn 11, Issue 3, 2001, Pages 203-208

  Mikova, O ^a   Yakimova, R ^a   Bosmans, E ^b,c   Kenis, G ^c   Maes, M ^c,d  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b Eurogenetics   (Belgium)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d VANDERBILT UNIVERSITY   (United States)

Author keywords

Cytokines; Depression; Interleukin; Multiple sclerosis; Tumor necrosis factor

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CLOMIPRAMINE; CYTOKINE; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; MIANSERIN; PAROXETINE; TUMOR NECROSIS FACTOR ALPHA; UTEROGLOBIN;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; INFLAMMATION; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

ADULT; ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS; BIOLOGICAL MARKERS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; INTERLEUKINS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PROTEINS; RECEPTORS, INTERLEUKIN-2; TUMOR NECROSIS FACTOR-ALPHA; UTEROGLOBIN;

EID: 0034964247     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(01)00081-5     Document Type: Article

References (43)

1. Human urinary protein 1: evidence for identity with the Clara cell protein and occurrence in respiratory tract and urogenital secretions
2. Vagotomy attenuates behavioural effects of interleukin-1 injected peripherally but not centrally
3. Tumour necrosis factor alpha mRNA expression in early multiple sclerosis lesions: correlation with demyelinating activity and oligodendrocyte pathology
4. Psychological and behavioral effects of interferons
5. Profile of cerebrospinal fluid and serum cytokines in patients with relapsing-remitting multiple sclerosis: a correlation with clinical activity
6. Clara cell protein: concentrations in cerebrospinal fluid, serum and amniotic fluid
7. Potent inhibition of both human interleukin-γ production and biologic activity by the Clara cell protein CC16
8. Circulating natural killer cell phenotypes in men and women with major depression
9. Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission
10. A rating scale for depression
11. Variations of IL2, IL6, TNF alpha plasmatic levels in relapsing remitting multiple sclerosis
12. Tumor necrosis factor identified in multiple sclerosis brain
13. Elevated serum levels of IFN-gamma, IL-4 and TNF-alpha/unelevated serum levels of IL-10 in patients with demyelinating diseases during the acute stage
14. Elevated levels of acute phase proteins in major depression
15. Cytokine production and treatment response in major depressive disorder
16. Brain neurotransmission during peripheral inflammation
17. Major depression and activation of the inflammatory response system
18. Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1 beta and soluble interleukin-2 receptor production
19. Disturbances in acute phase plasma proteins during melancholia: additional evidence for the presence of an inflammatory process during that illness
20. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression
21. Effects of pregnancy and delivery on serum concentrations of Clara cell protein (CC16): lower antenatal and postnatal serum CC16 is related to postpartum depression
22. Immunochemotherapy with interleukin-2 and/or interferon-alpha in cancer patients induces lowered serum dipeptidyl peptidase IV activity, which is related to therapy-induced depressive symptoms and immune activation
23. The role of the vagus nerve in cytokine-to-brain communication
24. Cloning and tissue-specific expression of the cDNA for the mouse Clara cell 10 kD protein: comparison of endogenous expression to rabbit uteroglobin promotor-driven transgene expression
25. Raised levels of plasma interleukin-1β in major and post viral depression
26. Multiple sclerosis is associated with an imbalance between tumour necrosis factor-alpha (TNF-alpha)- and IL-10-secreting blood cells that is corrected by interferon-beta (IFN-beta) treatment
27. CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis
28. Tumour necrosis factor alpha is elevated in serum and cerebrospinal fluid in multiple sclerosis and inflammatory neuropathies
29. Immunological differences between major depression and somatization disorder
30. Reduced preference for sucrose in autoimmune mice: a possible role of interleukin-6
31. Cytokine production and serum proteins in depression
32. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions
33. Detection of interleukin-6 in serum and cerebrospinal fluid of patients with neuroimmunological diseases
34. Clara cell 10 kDa protein (CC10): comparison of structure and function to uteroglobin
35. Multiple sclerosis: IL-2 and sIL-2R levels in cerebrospinal fluid and serum. Review of literature and critical analysis of ELISA pitfalls
36. Cytokines and treatment resistant depression
37. Indicators of immune activation in major depression
38. The inflammatory response system and the availability of tryptophan in patients with primary sleep disorders and major depression
39. Treatment-resistant depression
40. Comparative analysis of cytokine patterns in immunological, infectious, and oncological neurological disorders
41. Human CC10, the homologue of rabbit uteroglobin: genomic cloning, chromosomal localization and expression in endometrial cell lines
42. Behavioral and psychological effects of immune activation: implications for depression due to a general medical condition